Attached files
| file | filename |
|---|---|
| 10-K - ALTEROLA BIOTECH INC. | v208051_10k.htm |
| EX-14 - ALTEROLA BIOTECH INC. | v208051_ex14.htm |
| EX-23.1 - ALTEROLA BIOTECH INC. | v208051_ex23-1.htm |
| EX-31.2 - ALTEROLA BIOTECH INC. | v208051_ex31-2.htm |
| EX-32.2 - ALTEROLA BIOTECH INC. | v208051_ex32-2.htm |
| EX-31.1 - ALTEROLA BIOTECH INC. | v208051_ex31-1.htm |
| EX-21.1 - ALTEROLA BIOTECH INC. | v208051_ex21-1.htm |
Exhibit
No. 32.1
Form
10-K
Alterola
Biotech Inc.
Certification Pursuant to 18 U.S.C.
Section 1350, as Adopted
Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002
In
connection with the Annual Report of Alterola Biotech Inc. (the Company”) on
Form 10-K for the year ended September 30, 2010 as filed with the Securities and
Exchange Commission on the date hereof (the Report”), I, Soren Nielsen, Chief
Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
|
|
(1)
|
the
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
|
(2)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
January
13, 2011
|
By: /s/ Soren Nielsen
|
||||
|
Soren
Nielsen
|
|||||
|
Chief
Executive Officer
|
|||||
|
(Principal
Executive Officer)
|